Abstract

Awareness about prostate cancer has increased in the community, and prostate cancer screening examinations, including prostate specific antigen (PSA) assays, are now widely available. Prior to the PSA era, up to 27% of prostate cancers were detected incidentally at the time of transurethral resection of prostate (TURP). After PSA testing became widely available, the incidence of incidentally detected carcinoma prostate in TURP specimens without prior diagnosis reduced to 5-13%. However, the incidence of incidentally detected carcinoma prostate has been reported to vary across the globe since various factors can influence the identification of this malignancy in TURP specimens. In this paper, we focus on rates of incidentally detected prostate cancer in TURP specimens in our hospital and correlate it with various parameters. This retrospective study of histopathological findings of biopsy specimens was conducted for patients undergoing TURP during a period of 5 years from April 2010. The inclusion criteria were patients diagnosed with benign prostatic hyperplasia (BPH) (digital rectal examination (DRE) not showing any abnormally hard areas and normal age adjusted PSA values). Patients with elevated PSA, abnormal DRE, documented urinary tract infection and proved adenocarcinoma prostate (CaP) were excluded from the study. The total weight of prostatectomy specimen, occurrence of carcinoma prostate in the chips, percentage of total tissue resected showing malignancy and Gleason's scores were recorded. A total of 597 patients belonging to the inclusion criteria were studied. The incidence of occult CaP in the study group was 5.2 % (31/597). Out of these, 8 belonged to T1a and 23 belonged to T1b stages. The age group 70 - 79 years had the maximum incidence of occult CaP. It was observed that the clinical grading of prostate did not have a bearing on the incidence of occult CaP whereas the weight of resected specimen correlated with the incidence of CaP. The incidence of occult CaP was greater with low volume prostates (<20 g). (P=0.15). The rate of incidentally detected adenocarcinoma prostate in patients undergoing TURP for clinically diagnosed BPH was found to be only 5.2 % in our study which is low when compared with similar studies done elsewhere. The age of the patient and weight of the resected specimen correlated with incidence of occult prostate cancer. The clinical grading of prostate by DRE however, demonstrated no correlation.

Highlights

  • Prostate cancer is the fourth leading cancer in both sexes and the second most common cancer in males

  • Prior to the prostate specific antigen (PSA) era, up to 27% of prostate cancers were detected incidentally at the time of transurethral resection of prostate (TURP)

  • The inclusion criteria were patients diagnosed with benign prostatic hyperplasia (BPH) (digital rectal examination (DRE) not showing any abnormally hard areas and normal age adjusted PSA values)

Read more

Summary

Introduction

Prostate cancer is the fourth leading cancer in both sexes and the second most common cancer in males. Clinical T1a and T1b prostate cancer are diagnosed at the time of transurethral resection of the prostate (TURP) for benign prostatic disease. Prior to the PSA era, up to 27% of prostate cancers were detected incidentally at the time of TURP (Tombal et al, 1999). It may be necessary to redefine ‘‘true’’ incidental prostate cancer as carcinoma associated with a normal digital rectal examination (DRE) and a normal PSA level. Most of the incidental prostate cancers are considered clinically insignificant, recent studies have suggested that. DRE Grading vs Incidence of Prostate Cancer incidentally detected prostate cancer in TURP specimens in our hospital and correlate it with various parameters like age of the patient, weight of resected gland and clinical. Incidental CaP detected P value (% incidence) grading of prostate according to DRE

Materials and Methods
Findings
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call